A detailed history of Portside Wealth Group, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Portside Wealth Group, LLC holds 6,093 shares of ATRC stock, worth $200,459. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,093
Previous 6,497 6.22%
Holding current value
$200,459
Previous $213 Million 0.88%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

SELL
$29.24 - $37.87 $11,812 - $15,299
-404 Reduced 6.22%
6,093 $215 Million
Q2 2025

Aug 11, 2025

BUY
$29.07 - $34.94 $188,867 - $227,005
6,497 New
6,497 $213 Million
Q2 2023

Aug 01, 2023

BUY
$40.44 - $49.6 $3.36 Million - $4.13 Million
83,181 New
83,181 $4.11 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.53B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Portside Wealth Group, LLC Portfolio

Follow Portside Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portside Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portside Wealth Group, LLC with notifications on news.